CompletedPhase 1

Single Ascending Dose Study With 5-MeO-DMT in Healthy Subjects

United Kingdom36 participantsStarted 2021-09-22

Plain-language summary

The study will evaluate safety, tolerability and PK profile of 5-MeO-DMT in healthy subjects

Who can participate

Age range25 Years – 55 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: \* Medically healthy based on medical records and study specific assessments Exclusion Criteria: \* Presence or history of severe adverse reaction to any drug or drug excipient

What they're measuring

Percentage of subjects with treatment emergent AEs (TEAES)

Timeframe: From screening through to the follow up visit, up to 65 days

Trial details

NCT IDNCT05032833

SponsorBeckley Psytech Limited

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2022-07-07

View on ClinicalTrials.gov More Pharmacokinetics in Healthy Adults trials